Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Environmental
- Health and Safety
- Water and Wastewater
- Food and Beverage
- Energy
- Oil, Gas & Refineries
- Agriculture
- Air and Climate
- Manufacturing, Other
- Mining
- Aerospace & Air Transport
- Logistics
- Pulp & Paper
- Waste and Recycling
- Soil and Groundwater
- Government
- Publishing / Media / Marketing
Oncology Suppliers Serving Bahrain
334 companies found
based inLund, SWEDEN
BrainCool AB is a medtech company specializing in advanced cooling systems designed for medical emergencies and critical care applications. Their product lines, including BrainCool System, RhinoChill, and Cooral System, are designed to offer ...
based inFramingham, MASSACHUSETTS (USA)
At Definitive Healthcare, our passion is to transform data, analytics and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities and people, so they can shape tomorrow’s healthcare industry. Our ...
Developing new products means matching customers’ needs with accurate market sizes. Once you understand the market opportunity, you can focus on what’s most important. With Definitive Healthcare Solutions for Product Development, you ...
based inGuildford, UNITED KINGDOM
Datar Cancer Genetics is a leader in developing blood-based diagnostics that can detect cancer early, offer non-invasive investigations for better treatment options, and track the progression of the disease or its recurrence. We believe that ...
based inDuncan, SOUTH DAKOTA (USA)
What started in 2013 as a multi-disciplinary team of medical device engineers, scientists, imaging experts, software and hardware specialists, robotics technologists and clinicians focused on the development of an alternative to the limitations of ...
HDVI (High Definition Volumetric Imaging) is a new hybrid technology in CT (Computed Tomography) that provides unprecedented diagnostic and interventional information for clinicians. EPICA’s SeeFactor CT3™ is a multi-modality, mobile ...
based inGuangzhou, CHINA
Four E's Scientific, part of the FOUR E's Industrial Group established in 2009, is focused on providing Laboratories worldwide with high-quality instruments & supplies, thereby furthering Scientific Research. Today, we are one of the fastest growing ...
960406 Real-time PCR is a 96 well quantitative fluorescence Real-time PCR System, equipped with a 10.1-inch high-definition color touch screen and built-in analysis software for intuitive operation and analysis. Combining the innovative thermal ...
based inMoscow, RUSSIA
Our company provides development, implementation and operation of advanced technological solutions. Among the projects being implemented are industrial filtration systems for liquids, structured water devices, Ultraviolet bacteria disinfectant ...
The health card is a device for bioresonant magnetic therapy. Is a unique development of a group of Russian scientists based on the achievements of quantum physics. As part of the device bioactive in its properties, a magnetic system consisting of ...
based inBoston, MASSACHUSETTS (USA)
We can create human tissues and organs using cells from our own bodies, paving the way to make us our own organ donors, reducing organ rejection and solve the problem with lack of donors. We can save lives with faster and more accurate methods for ...
The high-throughput, fully automated biodispensing solution that leverages BIOPOD (bioprinting on demand) technology with pre-set and pre-validated protocols to bring the power of 3D cell biology to your ...
based inAbingdon, UNITED KINGDOM
PsiOxus is a clinical-stage company redefining therapies for solid tumors with the goal of curing patients with cancer. Our clinically validated, systemically dosed T-SIGn® viral vector platform delivers tumor-localized production of combinations of ...
Four transgenes: Producing an anti-FAP bispecific plus cytokines/chemokines. Currently in clinical trials in the US and UK. See our clinical trials page for more information. The aim of this study is to characterise the safety, tolerability and ...
based inAmherst, NEW HAMPSHIRE (USA)
BUHLMANN Diagnostics Corp (BDC), Amherst NH is the North American affiliate of BÜHLMANN Laboratories AG, a leading worldwide operative manufacturer of ELISA kits, RIA kits, lateral flow assay kits, flow cytometry assay kits and turbidimetric assays ...
based inSan Diego, CALIFORNIA (USA)
Invivoscribe is a global leader in molecular diagnostics, providing a comprehensive range of standardized, CE-marked in vitro diagnostic products and companion diagnostics for hematology-oncology. The company's offerings include research use only ...
based inTaipei, TAIWAN
Lumosa Therapeutics is a clinical-stage pharmaceutical company dedicating to develop novel therapies and solutions for neurological and oncological diseases with urgent unmet medical need. Besides of using Lumosa's own technology platform in drug ...
based inValencia, SPAIN
Quibim, with headquarters in Valencia, Spain, is a global leader in whole-body medical imaging analysis. Quibim products are used worldwide by leading research teams. Partners use Quibim Precision®, a whole-body imaging ecosystem, for a wide range ...
based inWaltham, MASSACHUSETTS (USA)
Evident, we’re building on this legacy with a continued commitment to pushing the limits of discovery. Today, as Evident, we’re building on a century of optical superiority to create next-generation micro-imaging solutions—combining renowned optics ...
based inGuangzhou City, CHINA
ZORAY Precision Technology Co., Ltd., with eight years of innovative experience, is a leader in delivering precision medical manufacturing solutions tailored for global markets. The company specializes in OEM and ODM capabilities, focusing on the ...
Produced in an ISO 13485-certified cleanroom, these needles are constructed for single-handed use and incorporate dual triggers, ultra-sharp trocars, and a deep sample notch for enhanced efficiency and cost-reduction. Ideal for ...
based inBedminster, NEW JERSEY (USA)
Jubilant Therapeutics Inc. is a clinical stage precision therapeutics company advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. With an advanced discovery engine which ...
Strong scientific and clinical rationale for novel small molecule PD-L1 ...
based inDowners Grove, ILLINOIS (USA)
Shared Imaging provides top-tier diagnostic imaging systems and services, optimizing MRI, PET/CT, CT, and Women's Health systems acquisition through innovative, cost-effective methods. Leveraging extensive expertise as owners, operators, and service ...
The decay of these tracers is detected by the PET scanner, which creates physiologic maps of relevant functions or processes. Clinically, FDG, a glucose analog, is commonly used to image glucose metabolic rates in oncologic studies, ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of ...
based inParsippany, NEW JERSEY (USA)
Interpace Biosciences (IDXG) is a dynamic and growing leader in the life sciences industry, providing complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. Since our ...
based inNew York, NEW YORK (USA)
Bureau Veritas is a recognized world leader in testing, inspection and certification services (TIC). Our mission is at the heart of key challenges: quality, health and safety, environmental protection and social responsibility. Through our wide ...
based inCambridge, UNITED KINGDOM
Our business is organised to deliver our strategic priorities sustainably, supporting continued scientific innovation and commercial success. We focus on the discovery, development and commercialisation of prescription medicines in Oncology and ...
Mechanism: BCL2/xL; Area under investigation: haematological malignancies; Date commenced phase: Q4 2019; Estimated Filing Acceptance: US: EU: Japan: China; Additional information: Partnered product. Molecule size: Small molecule; Status ...
